| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Virex Pharma is developing novel nanotechnology formulations of an antiviral drug for the treatment of infections caused by Respiratory Syncytial Virus (RSV), COVID-19 and Dengue virus |
| Category: | Hardware & devices, Health & biotech |
| URL: | https://virexpharma.com/ |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2020 |
| Address: | 28, 13 Cantonment Street, Fremantle, WA 6160, AU |
| State: | Western Australia |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/virex-pharma |
| Founders: |
No items found
|
| Awards won: | |
